Zhejiang Vie Science & Technology Co., Ltd. Financial Data
Consolidated
Consolidated Balance Sheet (B/S)(in CNY millions)
| FY ended Mar. 31, 2023 | FY ended Mar. 31, 2022 | FY ended Mar. 31, 2021 | |
| Current assets | 3,333.80 | 2,943.71 | 2,495.16 |
| Illiquid assets | 1,990.11 | 1,867.63 | 1,406.37 |
| Total assets | 5,323.90 | 4,811.34 | 3,901.53 |
| Current liabilities | 2,630.63 | 2,384.70 | 1,641.56 |
| Illiquid debts | 339.55 | 386.86 | 268.97 |
| Total liabilities | 2,970.17 | 2,771.56 | 1,910.53 |
| Capital | 479.65 | 479.65 | 479.65 |
| Capital reserve | 807.85 | 795.02 | 783.70 |
| Profit reserve | 117.08 | 98.41 | 98.05 |
| Backlog profit | 849.66 | 588.02 | 557.51 |
| Minority stock holders' equity | 86.08 | 76.90 | 72.09 |
| Total stockholders' equity | 2,353.73 | 2,039.78 | 1,991.00 |
| Total Liabilities and shareholders' equity | 5,323.90 | 4,811.34 | 3,901.53 |
Consolidated Profit and Loss Statement (in CNY millions)
| FY ended Mar. 31, 2023 | FY ended Mar. 31, 2022 | FY ended Mar. 31, 2021 | |
| Sales | 3,982.53 | 3,364.06 | 2,713.12 |
| Operating profit | 336.52 | 67.09 | (1.02) |
| Gross profit | 327.46 | 66.04 | 7.87 |
| Net profit | 317.62 | 66.79 | 10.02 |
Consolidated Cash Flow (in CNY millions)
| FY ended Mar. 31, 2023 | FY ended Mar. 31, 2022 | FY ended Mar. 31, 2021 | |
| Cash flows from operating activities | 269.55 | 72.49 | 48.34 |
| Cash flows from investing activities | (58.65) | (184.89) | (112.87) |
| Cash flows from financing activities | (106.26) | 150.25 | 35.85 |
| Gains (losses) from exchange-rate translation | 1.72 | 8.38 | (2.29) |
| Increases (decreases) in cash and cash equivalents | 106.35 | 46.23 | (30.96) |
| Cash and cash equivalent at the beginning of the term | 557.08 | 510.85 | 541.81 |
| Cash and cash equivalents at the term-end | 663.43 | 557.08 | 510.85 |
Non-Consolidated
Unconsolidated balance sheet (B/S) (in CNY millions)
| FY ended Mar. 31, 2023 | FY ended Mar. 31, 2022 | FY ended Mar. 31, 2021 | |
| Current assets | 1,324.34 | 1,182.58 | 1,299.29 |
| Illiquid assets | 1,645.50 | 1.520.52 | 1,467.59 |
| Total assets | 2,969.84 | 2,703.10 | 2,766.88 |
| Current liabilities | 875.09 | 750.71 | 805.90 |
| Illiquid debts |
196.78 |
190.93 |
176.73 |
| Total liabilities | 1,071.87 | 941.63 | 982.62 |
| Capital | 479.65 | 479.65 | 479.65 |
| Capital reserve | 789.48 | 789.63 | 775.57 |
| Profit reserve | 94.57 | 75.90 | 75.54 |
| Backlog profit | 524.55 | 415.97 | 453.51 |
| Total stockholders' equity | 1,897.98 | 1,761.47 | 1,784.26 |
| Total Liabilities and shareholders' equity | 2,969.84 | 2,703.10 | 2,766.88 |
Unconsolidated cash flow (in CNY millions)
| FY ended Mar. 31, 2023 | FY ended Mar. 31, 2022 | FY ended Mar. 31, 2021 | |
| Sales | 1,270.47 | 1,044.42 | 1,245.90 |
| Operating profit | 189.26 | 4.80 | (11.91) |
| Gross profit | 189.69 | 5.50 | (10.91) |
| Net profit | 186.70 | 3.59 | (2.15) |
Unconsolidated profit and loss statement (in CNY millions)
| FY ended Mar. 31, 2023 | FY ended Mar. 31, 2022 | FY ended Mar. 31, 2021 | |
| Cash flows from operating activities | 110.52 | 150.65 | 42.04 |
| Cash flows from investing activities | 48.78 | (70.53) | (147.12) |
| Cash flows from financing activities | (95.51) | (61.20) | (15.94) |
| Gains (losses) from exchange-rate translation | 1.35 | 8.13 | (2.40) |
| Increases (decreases) in cash and cash equivalents | 65.14 | 27.05 | (123.41) |
| Cash and cash equivalent at the beginning of the term | 250.71 | 223.65 | 347.06 |
| Cash and cash equivalents at the term-end | 315.85 | 250.71 | 223.65 |